Square Pharmaceuticals PLC. (DSE: SQURPHARMA)
Bangladesh
· Delayed Price · Currency is BDT 230.80
-0.40 (-0.17%)
At close: Sep 12, 2024
SQURPHARMA Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 11, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Market Capitalization | 204,593 | 185,977 | 192,094 | 191,030 | 145,631 | 208,535 | Upgrade
|
| Market Cap Growth | 3.77% | -3.18% | 0.56% | 31.17% | -30.16% | -3.51% | Upgrade
|
| Enterprise Value | 148,422 | 132,967 | 141,464 | 147,209 | 111,668 | 180,240 | Upgrade
|
| Last Close Price | 230.80 | 199.40 | 196.27 | 189.99 | 141.57 | 199.14 | Upgrade
|
| PE Ratio | 10.11 | 9.31 | 9.58 | 10.56 | 9.40 | 13.96 | Upgrade
|
| PS Ratio | 2.97 | 2.96 | 3.34 | 3.77 | 3.17 | 4.74 | Upgrade
|
| PB Ratio | 1.68 | 1.61 | 1.83 | 2.10 | 1.88 | 3.07 | Upgrade
|
| P/FCF Ratio | 19.79 | 32.51 | 28.71 | 26.61 | 16.70 | 20.16 | Upgrade
|
| P/OCF Ratio | 13.60 | 21.76 | 14.92 | 17.40 | 13.53 | 16.83 | Upgrade
|
| EV/Sales Ratio | 2.16 | 2.12 | 2.46 | 2.90 | 2.43 | 4.09 | Upgrade
|
| EV/EBITDA Ratio | 6.44 | 7.00 | 7.57 | 8.58 | 7.07 | 11.73 | Upgrade
|
| EV/EBIT Ratio | 7.33 | 7.97 | 8.39 | 9.64 | 8.05 | 13.50 | Upgrade
|
| EV/FCF Ratio | 14.36 | 23.24 | 21.14 | 20.51 | 12.81 | 17.43 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.00 | - | - | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.10 | 0.10 | 0.01 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.15 | 0.35 | 0.29 | 0.01 | - | - | Upgrade
|
| Asset Turnover | 0.56 | 0.54 | 0.56 | 0.57 | 0.60 | 0.66 | Upgrade
|
| Inventory Turnover | 2.93 | 3.19 | 3.72 | 3.94 | 4.50 | 5.01 | Upgrade
|
| Quick Ratio | 11.19 | 13.29 | 14.30 | 14.56 | 10.91 | 9.94 | Upgrade
|
| Current Ratio | 14.39 | 16.67 | 17.03 | 17.33 | 14.62 | 12.93 | Upgrade
|
| Return on Equity (ROE) | 17.52% | 17.22% | 18.52% | 18.96% | 18.39% | 20.13% | Upgrade
|
| Return on Assets (ROA) | 8.99% | 8.93% | 10.17% | 10.77% | 11.26% | 12.51% | Upgrade
|
| Return on Capital (ROIC) | 9.41% | 9.30% | 10.64% | 11.34% | 11.94% | 13.27% | Upgrade
|
| Earnings Yield | 9.89% | 10.21% | 9.45% | 8.35% | 9.17% | 6.06% | Upgrade
|
| FCF Yield | 5.05% | 3.08% | 3.48% | 3.76% | 5.99% | 4.96% | Upgrade
|
| Dividend Yield | 4.55% | 5.27% | 5.09% | 3.16% | 3.16% | 1.88% | Upgrade
|
| Payout Ratio | 45.63% | 46.38% | 29.20% | 24.60% | 24.82% | 20.99% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | 0.00% | 0.00% | Upgrade
| |
| Total Shareholder Return | 4.55% | 5.27% | 5.09% | 3.16% | 3.16% | 1.88% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.